Ascletis Pharma, Inc. (1672) Income Statement

Last quarter (Q2 2024), Ascletis Pharma, Inc.'s total revenue was ¥0.00, a decrease of -100.00% from the same quarter last year. In Q2, Ascletis Pharma, Inc.'s net income was ¥-65.16M. See Ascletis Pharma, Inc.’s key income statements, including revenue, expenses, profit, and income.